TCL Archive New Phase III Trial Reviews Approve 25%; Should Trialists Worry? Not Yet, January 19, 2007
TCL Archive Yervoy-Nivolumab Combination Treatment Shrinks Tumors 80 Percent in Three Months May 31, 2013